Skip to content

To study the efficacy of Dashmoola kwath Kavala In Dantaharsha with special reference to Dentine Hypersensitivity

Randomized controlled clinical trial to evaluate the efficacy of Dashmoola Kwath Kaval in Dantaharsha with special reference to Dentine Hypersensitivity. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082873
Enrollment
50
Registered
2025-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z00-Z99- Factors influencing health status and contact with health services Health Condition 2: 8- Other Procedures

Interventions

None listed

Sponsors

LRP Ayurvedic Medical College and research institute islampur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having signs and symptoms of dantaharsha 2.Patients between 5-70 age group 3.irrespective of gender ,caste,economical class,

Exclusion criteria

Exclusion criteria: 1. Patients having dantaharsha with other oral problems like mouth ulcers ,etc. 2.patients below 5 and above 70 of age 3. Patients having systemic disease with complication which can lead to interference with the study . 4. Mentally Retarded patients 5. Congenital anomalies of the teeth like Anodontia, Ectodermal Dyplasia ,etc

Design outcomes

Primary

MeasureTime frame
To Study the efficacy of dashmoola kwath kavala in the management of Dantaharsha with special reference to dentin hypersensitivity .Timepoint: 15 days

Secondary

MeasureTime frame
To study the conceptual literature of Dantaharsha in detail. To study the conceptual literature of dentine hypersensitivity in detail. Preparation of dashmoola kwath Timepoint: 15 days

Countries

India

Contacts

Public ContactDR Pravin Chavan

LRP Ayurvedic Medical College, Sangl

drpravin999@gmail.com9822338613

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026